Wolverine Stack
BPC-157 + TB-500
Accelerate injury recovery, reduce inflammation, and promote comprehensive tissue repair
Overview
The most popular peptide stack in the community, named for its regenerative properties reminiscent of the X-Men character. Combines two complementary healing peptides that work through different mechanisms — BPC-157 for localized tissue repair and angiogenesis, and TB-500 for systemic cell migration and anti-inflammatory effects.
Component Peptides
Primary healing agent — promotes angiogenesis, tendon/ligament repair, and GI mucosal healing
Systemic tissue repair — promotes cell migration, reduces inflammation, and supports actin regulation
Expected Timeline
Initial improvements in pain and inflammation within 1-2 weeks. Significant tissue repair typically reported at 4-6 weeks. Full protocol benefits by 8-12 weeks.
Safety Notes
- Both peptides are WADA-prohibited substances
- BPC-157 may theoretically promote tumor angiogenesis — avoid if cancer history
- TB-500 should be avoided in active cancer due to cell proliferation effects
- No known serious adverse events in community reports at standard doses
- Injection site reactions (redness, swelling) are the most common side effect
Bloodwork Recommendations
- Baseline CRP and ESR (inflammation markers)
- CBC with differential
- Liver function panel (ALT, AST)
- Consider imaging (MRI/ultrasound) before and after for objective assessment
Contraindications
- Active cancer or history of cancer
- Competitive athletes subject to WADA drug testing
- Pregnancy or breastfeeding
- Known hypersensitivity to either peptide
Evidence Assessment
Both peptides have strong preclinical (animal) evidence individually. BPC-157 has extensive rodent studies showing tissue repair across multiple systems. TB-500 (thymosin beta-4) has wound healing data. However, there are no published human clinical trials for either peptide individually, and no studies examining the combination.
References
- Sikiric P, et al. "Brain-gut Axis and Pentadecapeptide BPC 157." Curr Neuropharmacol. 2016;14(8):857-865.
- Goldstein AL, et al. "Thymosin beta4: a multi-functional regenerative peptide." Expert Opin Biol Ther. 2012;12(1):37-51.
- Sosne G, et al. "Thymosin beta 4 and the eye." Ann N Y Acad Sci. 2012;1269:92-98.
Research Disclaimer: The information on this page is for educational purposes only and does not constitute medical advice. All products referenced are for in vitro laboratory research use only. Consult a qualified healthcare professional before beginning any research protocol.